Ken Fisher acquired 13.6 Thousand Sarepta Therapeutics shares worth $1.15 Million. That's 0.00% of their equity portfolio (708th largest holding). The first Sarepta Therapeutics trade was made in Q3 2017. Since then Ken Fisher bought shares ten more times and sold shares on fourteen occasions. The stake costed the investor $938 Thousand, netting the investor a gain of 23% so far.